# A Study of IBI311 in Healthy Volunteers

> **NCT05480579** · PHASE1 · COMPLETED · sponsor: **Innovent Biologics (Suzhou) Co. Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** placebo
- **BIOLOGICAL:** IBI311
- **BIOLOGICAL:** IBI311
- **BIOLOGICAL:** placebo
- **BIOLOGICAL:** placebo
- **BIOLOGICAL:** IBI311
- **BIOLOGICAL:** IBI311
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT05480579
- **Lead sponsor:** Innovent Biologics (Suzhou) Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-10
- **Primary completion:** 2022-11-23
- **Final completion:** 2023-01-19
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05480579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05480579, "A Study of IBI311 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05480579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*